HIMSHims & Hers Health, Inc.

NYSE forhims.com


$ 12.92 $ 0.77 (6.34 %)    

Thursday, 09-May-2024 15:59:52 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 3.37 (0.65 %)
TLT $ 90.69 $ 0.50 (0.55 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 12.92
$ 12.29
$ 0.00 x 0
$ 0.00 x 0
$ 12.24 - $ 13.01
$ 5.65 - $ 17.16
12,703,632
na
2.79B
$ 0.86
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-06-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-07-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-22-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-27-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-29-2019 06-30-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-hims--hers-health-stock-is-rising-today

After the market close on Monday, Hims & Hers Health reported strong first-quarter results that included revenue of $278.2 ...

 hims--hers-healths-model-proving-effective-2-analysts-examine-q1-earnings

Hims & Hers Health reported total revenue of $278.2 million, a 46% year-on-year growth and higher than Street expectations ...

 deutsche-bank-maintains-hold-on-hims--hers-health-raises-price-target-to-16

Deutsche Bank analyst George Hill maintains Hims & Hers Health (NYSE:HIMS) with a Hold and raises the price target from ...

Core News & Articles
Market-Moving News for May 7th
05/07/2024 12:36:21

CMND: 60% | Clearmind Medicine shares are trading higher after the company signed an exclusive patent licensing agreement with ...

 piper-sandler-maintains-neutral-on-hims--hers-health-raises-price-target-to-13

Piper Sandler analyst Korinne Wolfmeyer maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and raises the price tar...

 palantir-boeing-lucid-group-hims--hers-tesla-why-these-5-stocks-are-on-investors-radars-today

On Monday, major U.S. stock indexes experienced gains, with the S&P500 closing nearly 1% higher at 5,180.74

 hims--hers-health-reports-better-than-expected-q1-results-strong-guidance

Hims & Hers Health reported quarterly GAAP earnings of 5 cents per share which beat the analyst consensus estimate of 2 cen...

 hims--hers-health-q1-2024-gaap-eps-005-beats-002-estimate-sales-278171m-beat-270382m-estimate

Hims & Hers Health (NYSE:HIMS) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of ...

Core News & Articles

TSLAPLTRALCCAAPLHOODNVDABADISDJTHIMSData from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment 

 hims--hers-health-ceo-under-fire-after-expressing-support-for-pro-palestinian-student-protesters-company-stock-plummets

Hims & Hers Health Inc. (NYSE: HIMS) stock was hit significantly on Friday following its CEO's public support for pro-P...

 jefferies-downgrades-hims--hers-health-to-hold-lowers-price-target-to-15

Jefferies analyst Glen Santangelo downgrades Hims & Hers Health (NYSE:HIMS) from Buy to Hold and lowers the price target...

 canaccord-genuity-initiates-coverage-on-hims--hers-health-with-buy-rating-announces-price-target-of-20

Canaccord Genuity analyst Maria Ripps initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Buy rating and announc...

 lamb-weston-reports-weak-earnings-joins-paragon-28-resources-connection-and-other-big-stocks-moving-lower-on-thursday

U.S. stocks were higher, with the Dow Jones gaining over 150 points on Thursday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION